TriSalus Life Sciences Inc (TLSI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
TriSalus Life Sciences, Inc. (TLSI)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points TriSalus Life Sciences Inc ( NASDAQ:TLSI ) reported strong financial results for Q4 2025, with revenues of $13.2 million, representing a 60% increase year-over-year. The company achieved its revenue growth guidance for the 2025 fiscal year, with full-year revenues reaching $45.2 million, a 53% increase over the prior year. TriSalus Life Sciences Inc ( NASDAQ:TLSI ) successfully raised $46 million in a public offering, which was more than two times oversubscribed, indicating strong investor confidence. The company is expanding its product portfolio from two to seven differentiated offerings, enhancing its market position and sales potential. TriSalus Life Sciences Inc ( NASDAQ:TLSI ) is investing in foundational clinical studies to validate its PEDD platform, which is expected to fuel g
Show less
Read more
Impact Snapshot
Event Time:
TLSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLSI alerts
High impacting TriSalus Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
TLSI
News
- TriSalus Life Sciences (TLSI) had its price target lowered by Canaccord Genuity Group Inc. from $12.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- TriSalus Life Sciences Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue GuidanceBusiness Wire
TLSI
Earnings
- 3/5/26 - Miss
TLSI
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/26/26 - Form 424B5
- TLSI's page on the SEC website